TET1 and neoplasm: The latter effect was ascribed to the finding that NAD metabolism drives interferon γ (IFNγ)-induced PD-L1 expression in tumor cells via an activated NAMPT–TET1–pSTAT1–IRF1–PD-L1 axis, which in turn promotes tumor immune invasion in a CD8+ T cell-dependent manner [201].